Transdermal patches having ionized beam crosslinked polymers and improved release characteristics
AssigneeSpecialty Pharmaceutical Products LLC
InventorsMatthew Harriton, Gregory Robb, Ronald S. Harland
Life of this patent
Estimating the term…
Loading patent…
AssigneeSpecialty Pharmaceutical Products LLC
InventorsMatthew Harriton, Gregory Robb, Ronald S. Harland
Estimating the term…
Crosslinked hydrogel-based transdermal pharmaceutical formulations. The hydrogel transdermal formulations. Transdermal patches are useful for administering a variety of drugs to patients. The transdermal patches here employ crosslinked-hydrogels generated through irradiation, thus eliminating any residual effects associated with chemical- or UV-based crosslinking procedures. The transdermal patches may be formed from a variety of high-molecular weight polymeric compounds and include substantial levels of water to improve skin tolerance by the patient. The transdermal patches may also include transcutol as a solvent for the drug, which has been found to increase the effectiveness of drug delivery. The present disclosure also provides for methods of loading a drug into a transdermal formulation after the crosslinking of the hydrogel, thus improving stability and bioavailability through avoiding exposure of the drug to the radiation used in the crosslinking procedure. The transdermal patches here are particularly effective in delivering lidocaine to patients in need thereof.
A transdermal formulation for administering lidocaine to a patient in need thereof, comprising:
Dependencies are inferred from the claim text.